Sonoma Pharmaceuticals Inc
SNOA
|
|
| |
|
| Trading Volume | 15,002 |
|
|
1.02 - 0.13 |
| Market Cap Full | $ 2.2M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | -7.8% | -12.9% | -16.1% |
| Q2 | - | -5.2% | 11.7% | -25.1% |
| Q3 | - | - | -29.2% | -27.1% |
| Q4 | - | - | -76.7% | -47.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 2.8 | -20.5 | 12.9 | -12.7 | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 48.2 | -26.5 | -20 | -2.7 | 1.1 | 13.5 | -0.9 | -19.3 | -11.5 | -78.8 | 7.9 | 1.7 |
| 2022 | |||||||||||
| -21.1 | -13.4 | 22.6 | -31.8 | 32 | -16.8 | 0.3 | -5.1 | -23.4 | -6.6 | -14.1 | -34.5 |
| 2021 | |||||||||||
| 14.2 | -2.9 | -9.2 | 6.4 | -1.9 | -3.8 | -9.1 | -5 | -9.1 | 0.1 | -8.2 | -12.3 |
| 2020 | |||||||||||
| 21.6 | -1.6 | -5.8 | 3.7 | 90.9 | -26.6 | 28.9 | -20.1 | 15.3 | -12.3 | -8.5 | 7.1 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -1.1 | -1.8 | -0.9 |
| Q2 | -0.3 | -0.3 | -0.5 | 0.1 |
| Q3 | -0.3 | -0.3 | -0 | 0.1 |
| Q4 | 0 | -0.6 | -0.3 | -0.3 |
| A | -0.86 | -1.5 | -1.9 | -1 |